Canada markets closed
  • S&P/TSX

    19,203.70
    +2.40 (+0.01%)
     
  • S&P 500

    4,141.59
    +13.60 (+0.33%)
     
  • DOW

    33,677.27
    -68.13 (-0.20%)
     
  • CAD/USD

    0.7974
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    60.57
    +0.39 (+0.65%)
     
  • BTC-CAD

    79,422.58
    +3,323.91 (+4.37%)
     
  • CMC Crypto 200

    1,360.73
    +66.74 (+5.16%)
     
  • GOLD FUTURES

    1,744.40
    -3.20 (-0.18%)
     
  • RUSSELL 2000

    2,228.92
    -4.86 (-0.22%)
     
  • 10-Yr Bond

    1.6230
    -0.0520 (-3.10%)
     
  • NASDAQ futures

    13,965.75
    -10.00 (-0.07%)
     
  • VOLATILITY

    16.65
    -0.26 (-1.54%)
     
  • FTSE

    6,890.49
    +1.37 (+0.02%)
     
  • NIKKEI 225

    29,664.97
    +126.27 (+0.43%)
     
  • CAD/EUR

    0.6664
    -0.0009 (-0.13%)
     

Theratechnologies to Present at the H.C. Wainwright Global Life Sciences Conference

  • Oops!
    Something went wrong.
    Please try again later.
Theratechnologies
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held virtually March 9 – 10, 2021.

The presentation will be available on demand beginning Tuesday, March 9, 2021 at 7:00 a.m. ET on the ‘News’ section of the Company’s website or via the virtual conference link, and will be archived for 90 days.

About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800

For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009